|
⚲
|
| Keyboard |
| Douglas Onsi | |
|---|---|
| Firm | |
| Address | 47 Thorndike Street Suite B11 Cambridge, MA 02141 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Leap Therapeutics Inc | 021-475708 | Executive Officer | 77.2 M of 77.2 M |
||
| Leap Therapeutics Inc | 021-299736 | Executive Officer | 18.0 M of 18.0 M |
||
| Tetralogic Pharmaceuticals Corp | 021-188311 | Director | 5.0 M of 10.0 M |
||
| Apellis Pharmaceuticals Inc | 021-181753 | Director | 0.7 M of 3.0 M |
||
| Tensha Therapeutics Inc | 021-164058 | Executive Officer | 0.5 M of 15.0 M |
||
| Apofore Corp | 021-163739 | Executive Officer | 0.5 M of 10.0 M |
||
| Apellis Pharmaceuticals Inc | 021-160587 | Director | 3.0 M of 4.2 M |
||
| Dekkun Corp | 021-153226 | Executive Officer | 9.9 M of 30.5 M |
||
| Anexon Inc | 021-149307 | Executive Officer | 2.0 M of 12.0 M |
||
| Shape Pharmaceuticals Inc | 021-148863 | Executive Officer | 1.0 M of 4.5 M |
||
| Shape Pharmaceuticals Inc | 021-148861 | Executive Officer | 2.0 M of 2.0 M |
||
| Sequoia Pharmaceuticals Inc | 021-39714 | Director | 3.8 M of 5.6 M |
||
| HCV Management VIII LLC | |||||
| Healthcare Ventures IX LP | 021-141176 | Director | of 250.0 M |
||